Halox Lotion contains Halobetasol 0.05% w/v, a potent topical corticosteroid indicated for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Halobetasol exerts anti-inflammatory, antipruritic, and vasoconstrictive effects by modulating the release of inflammatory mediators and suppressing immune responses in the skin. Halox Lotion is primarily prescribed for conditions such as psoriasis, eczema, atopic dermatitis, and lichen planus, where rapid relief of inflammation and itching is desired. The lotion formulation allows for easy application and absorption, making it suitable for use on hairy or large surface areas. It is recommended for short-term use due to the risk of adverse effects associated with potent corticosteroids, including skin atrophy, telangiectasia, and potential systemic absorption leading to hypothalamic-pituitary-adrenal axis suppression. Patients should apply a thin layer to the affected area once or twice daily as directed by a healthcare professional, avoiding occlusive dressings unless advised. Halox Lotion is contraindicated in patients with hypersensitivity to halobetasol or any formulation components, and should not be used on infected or ulcerated skin. Caution is advised in pediatric populations and during pregnancy or lactation. Proper adherence to dosing instructions minimizes risks and maximizes therapeutic benefits.